AUGMENT PHASE III STUDY: LENALIDOMIDE/RITUXIMAB (R2) IMPROVED EFFICACY OVER RITUXIMAB/PLACEBO IN RELAPSED/REFRACTORY FOLLICULAR PATIENTS IRRESPECTIVE OF POD24 STATUS
Authors:
Open Access
- 12 June 2019
- journal article
- research article
- Published by Wiley in Hematological Oncology
- Vol. 37 (S2) , 114-115